Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China

Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China

Abstract Background Currently available injectable agents are inadequate to address the high drug-resistant tuberculosis (DR-TB) burden in China. Regimens including the oral agent bedaquiline have been shown to be efficacious and safe, leading to its incorporation into multiple national TB treatment...

Full description

Bibliographic Details
Main Authors: Abela Mpobela Agnarson, Xiao Chun Wang, Ravi Potluri, Hitesh Bhandari, Amit Dhir, Chrispin Kambili, Laurent Metz
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Infectious Diseases
Subjects:
Drug-resistant tuberculosis
Bedaquiline
China
Disease burden
DR-TB
State-transmission model
Online Access:https://doi.org/10.1186/s12879-020-4795-4

Internet

https://doi.org/10.1186/s12879-020-4795-4

Similar Items